Tasmanians are expected to be able to access a Moderna Covid vaccine manufactured in Australia later this year.
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.
Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...
The S&P 500 plunged by 1.7% on Friday, Feb. 21, as weak economic data and earnings forecasts sent the benchmark index lower for the second straight session.
COVID-19: The virus does not enter human cells as readily as SARS-CoV-2 does, the Chinese researchers reported in the journal ...
Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...
Still, Mafi says there aren't strong data on how Paxlovid affects the disease course in people who are vaccinated. His findings suggest that the benefits are about four times smaller than those ...
14h
News Medical on MSNUCLA study finds no significant benefit of paxlovid for vaccinated older adultsPaxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results